Efficacy and safety of canakinumab in Schnitzler syndrome : A multicenter randomized placebo-controlled study

Krause, Karoline; Tsianakas, Athanasios; Wagner, Nicola; Weller, Karsten; Metz, Martin; Church, Martin K.; Maurer, Marcus; Fischer, Jörg

dc.contributor.author	Fischer, Jörg
dc.date.accessioned	2018-02-12T09:50:46Z
dc.date.available	2018-02-12T09:50:46Z
dc.date.issued	2017
dc.identifier.issn	1097-6825
dc.identifier.uri	http://hdl.handle.net/10900/80223
dc.language.iso	en	de_DE
dc.publisher	Mosby - Elsevier	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.jaci.2016.07.041	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Efficacy and safety of canakinumab in Schnitzler syndrome : A multicenter randomized placebo-controlled study	de_DE
dc.type	Article	de_DE
utue.quellen.id	20170815222223_01309
utue.publikation.seiten	1311-1320	de_DE
utue.personen.roh	Krause, Karoline
utue.personen.roh	Tsianakas, Athanasios
utue.personen.roh	Wagner, Nicola
utue.personen.roh	Weller, Karsten
utue.personen.roh	Metz, Martin
utue.personen.roh	Church, Martin K.
utue.personen.roh	Maurer, Marcus
utue.personen.roh	Fischer, Jörg
dcterms.isPartOf.ZSTitelID	Journal of Allergy and Clinical Immunology	de_DE
dcterms.isPartOf.ZS-Issue	4	de_DE
dcterms.isPartOf.ZS-Volume	139	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE